Judith E. Karp - Publications, H-index & Citations

Judith E. Karp

university of southern california keck hospital

78H指数

484论文数

1.9W被引数

收录论文 64

发表时间

B A NOVEL, POOLED, HIGH-THROUGHPUT SCREENING OF A CNS PENETRANT COMPOUND LIBRARY IDENTIFIES POTENTIAL BIOMARKER-DRIVEN THERAPEUTICS FOR GLIOBLASTOMA B 一种新颖的、组合式、高通量筛选方法对一种能够穿透中枢神经系统的化合物库进行筛选，以识别潜在的可由生物标志物驱动的胶质母细胞瘤治疗药物

NEURO-ONCOLOGY

IF13.4

2025-10-01

OAAI

Sulman, E. P.; Zhang, Z.; Ding, Y.; Ezhilarasan, R.; Graciani, M.; McManus, G.; Modrek, A.; Karp, J.

Genomic testing and patient rights

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2024-02-27

OAAI

Jones, C. Michael; Karp, Judith; Davis, Dena S.

Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification

LEUKEMIA

IF13.4

2023-07-31

OAAI

Hochman, Michael J.; Othus, Megan; Hasserjian, Robert P.; Ambinder, Alex; Brunner, Andrew; Percival, Mary-Elizabeth M.; Hourigan, Christopher S.; Swords, Ronan; DeZern, Amy E.; Estey, Elihu H.; Karp, Judith E.

Systematic review and meta-analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia 系统评价和荟萃分析: 急性髓系白血病患者从诊断到治疗的时间对预后的影响

CANCER

IF5.1

2023-05-31

PREAI

Franco, Stephanie; Geng, Xue; Korostyshevskiy, Valeriy; Karp, Judith E.; Lai, Catherine

Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia

HEMATOLOGICAL ONCOLOGY

IF3.9

2021-09-09

PREAI

Doucette, Kimberley; Percival, Mary-Elizabeth; Williams, Lacey; Kandahari, Adrese; Taylor, Allison; Wang, Shuqi; Ahn, Jaeil; Karp, Judith E.; Lai, Catherine

Advances in therapeutic options for newly diagnosed, high-risk AML patients

THERAPEUTIC ADVANCES IN HEMATOLOGY

IF3.1

2021-05-05

OAAI

Doucette, Kimberley; Karp, Judith; Lai, Catherine

CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia

CANCER RESEARCH

IF16.6

2021-01-07

OAAI

Ding, Husheng; Vincelette, Nicole D.; McGehee, Cordelia D.; Kohorst, Mira A.; Koh, Brian D.; Venkatachalam, Annapoorna; Meng, X. Wei; Schneider, Paula A.; Flatten, Karen S.; Peterson, Kevin L.; Correia, Cristina; Lee, Sun-Hee; Patnaik, Mrinal; Webster, Jonathan A.; Ghiaur, Gabriel; Smith, B. Douglas; Karp, Judith E.; Pratz, Keith W.; Li, Hu; Karnitz, Larry M.; Kaufmann, Scott H.

Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?

LEUKEMIA

IF13.4

2020-01-08

PREAI

Estey, Elihu; Karp, Judith E.; Emadi, Ashkan; Othus, Megan; Gale, Robert Peter

Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS

LEUKEMIA

IF13.4

2020-01-03

OAAI

Zeidner, Joshua F.; Knaus, Hanna A.; Zeidan, Amer M.; Blackford, Amanda L.; Montiel-Esparza, Raul; Hackl, Hubert; Prince, Gabrielle T.; Gondek, Lukasz P.; Ghiaur, Gabriel; Showel, Margaret M.; DeZern, Amy E.; Pratz, Keith W.; Smith, B. Douglas; Levis, Mark J.; Gore, Steven; Coombs, Catherine C.; Foster, Matthew C.; Streicher, Howard; Karp, Judith E.; Luznik, Leo; Gojo, Ivana

A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2018-11-15

OAAI

Litzow, Mark R.; Wang, Xin V.; Carroll, Martin P.; Karp, Judith E.; Ketterling, Rhett P.; Zhang, Yanming; Kaufmann, Scott H.; Lazarus, Hillard M.; Luger, Selina M.; Paietta, Elisabeth M.; Pratz, Keith W.; Tun, Han Win; Altman, Jessica K.; Broun, Edward R.; Rybka, Witold B.; Rowe, Jacob M.; Tallman, Martin S.

Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy AML患者CD8 T细胞功能障碍的特征及其与化疗反应的可逆性

JCI INSIGHT

IF6.1

2018-11-02

158

OAAI

Knaus, Hanna A.; Berglund, Sofia; Hackl, Hubert; Blackford, Amanda L.; Zeidner, Joshua F.; Montiel-Esparza, Rail; Mukhopadhyay, Rupkatha; Vanura, Katrina; Blazar, Bruce R.; Karp, Judith E.; Luznik, Leo; Gojo, Ivana

Population pharmacokinetics and site of action exposures of veliparib with topotecan plus carboplatin in patients with haematological malignancies 血液系统恶性肿瘤患者的群体药代动力学和维利帕尼与拓扑替康加卡铂的作用部位暴露

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2017-03-19

OAAI

Mehrotra, Shailly; Gopalakrishnan, Mathangi; Gobburu, Jogarao; Greer, Jacqueline M.; Piekarz, Richard; Karp, Judith E.; Pratz, Keith; Rudek, Michelle A.

Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo 急性髓性白血病和骨髓增生异常综合征造血干细胞和祖细胞体外药物敏感性评估

STEM CELLS TRANSLATIONAL MEDICINE

IF4.9

2016-11-07

OAAI

Knorr, Katherine L. B.; Finn, Laura E.; Smith, B. Douglas; Hess, Allan D.; Foran, James M.; Karp, Judith E.; Kaufmann, Scott H.

Association of acute myeloid leukemia's most immature phenotype with risk groups and outcomes

HAEMATOLOGICA

IF7.9

2016-01-27

OAAI

Gerber, Jonathan M.; Zeidner, Joshua F.; Morse, Sarah; Blackford, Amanda L.; Perkins, Brandy; Yanagisawa, Breann; Zhang, Hao; Morsberger, Laura; Karp, Judith; Ning, Yi; Gocke, Christopher D.; Rosner, Gary L.; Smith, B. Douglas; Jones, Richard J.

Cancer susceptibility genes and their potential implication regarding systemic therapy for early-stage breast cancer

CANCER

IF5.1

2015-12-07

OAAI

Karp, Judith E.; Wolff, Antonio C.

Histone Deacetylase Inhibitors Target the Leukemic Microenvironment by Enhancing a Nherf1-Protein Phosphatase 1α-TAZ Signaling Pathway in Osteoblasts 组蛋白去乙酰化酶抑制剂通过增强成骨细胞Nherf1-Protein磷酸酶1α-TAZ信号通路靶向白血病微环境

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2015-12-01

OAAI

Kremer, Kimberly N.; Dudakovic, Amel; Hess, Allan D.; Smith, B. Douglas; Karp, Judith E.; Kaufmann, Scott H.; Westendorf, Jennifer J.; van Wijnen, Andre J.; Hedin, Karen E.

Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2015-11-09

OAAI

Zeidner, Joshua F.; Karp, Judith E.; Blackford, Amanda L.; Foster, Matthew C.; Dees, E. Claire; Smith, Gary; Ivy, S. Percy; Harris, Pamela

CPX-351 (cytarabine: daunorubicin liposome for injection) anti-leukemia activity is potentiated by Chk1 inhibition CPX-351 (阿糖胞苷: 注射用柔红霉素脂质体) 抗白血病活性被Chk1抑制增强

CANCER RESEARCH

IF16.6

2015-08-01

PREAI

Vincelette, Nicole D.; Karnitz, Larry M.; Karp, Judith E.; Smith, Douglas B.; Hess, Allan D.; Mayer, Lawrence D.; Kaufmann, Scott H.

Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas

JOURNAL OF NEURO-ONCOLOGY

IF3.1

2015-06-13

OAAI

Campian, Jian L.; Ye, Xiaobu; Gladstone, Douglas E.; Ambady, Prakash; Nirschl, Thomas R.; Borrello, Ivan; Golightly, Marc; King, Karen E.; Holdhoff, Matthias; Karp, Judith; Drake, Charles G.; Grossman, Stuart A.

MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors

CELL DEATH AND DIFFERENTIATION

IF15.4

2015-06-05

OAAI

Knorr, K. L. B.; Schneider, P. A.; Meng, X. W.; Dai, H.; Smith, B. D.; Hess, A. D.; Karp, J. E.; Kaufmann, S. H.

研究方向